AS

Ankur Singh

Active Director Director DIN 09626603
DIN 09626603 First appointment May 2022 Primary industry Non-Profit Organizations
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankur Singh

Data last updated:

Ankur Singh is a Director at Greentree Pharmaceuticals Private Limited (since 2022). The company operates in Non-Profit Organizations.

DIN 09626603
Primary Designation Director
Industry Non-Profit Organizations
First Appointment 31 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 May 20222022Active

Board colleagues of Ankur Singh

NameDINCompanyDesignation
Himanshu09626604Greentree Pharmaceuticals Private LimitedDirector
Sunil Kumar09675222Greentree Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Greentree Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ankur Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankur Singh

Ankur Singh currently holds 1 directorship: Greentree Pharmaceuticals Private Limited (Director, since 31 May 2022).

Ankur Singh was first appointed on 31 May 2022 as Director at Greentree Pharmaceuticals Private Limited.

The current boards of Ankur Singh's companies include Himanshu (Greentree Pharmaceuticals Private Limited), Sunil Kumar (Greentree Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available